Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats

Benedetti, 1996, The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia., Pain, 64, 535, 10.1016/0304-3959(95)00179-4 Boden, 1994, Ionic mechanisms underlying cholecystokinin action in rat brain., Ann NY Acad Sci, 713, 129, 10.1111/j.1749-6632.1994.tb44059.x Cox, 1995, Cholecystokinin depolarizes rat thalamic reticular neurons by suppressing a K conductance., J Neurophysiol, 74, 990, 10.1152/jn.1995.74.3.990 Cheng, 1986, Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons., Brain Res, 375, 57, 10.1016/0006-8993(86)90958-3 Dourish, 1990, The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat., Eur J Pharmacol, 176, 35, 10.1016/0014-2999(90)90129-T Faris, 1983, Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia., Science, 219, 310, 10.1126/science.6294831 Fields, 1991, Neurotransmitters in nociceptive modulatory circuits., Annu Rev Neurosci, 14, 219, 10.1146/annurev.ne.14.030191.001251 Fields, 1995, Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla., J Neurophysiol, 74, 1742, 10.1152/jn.1995.74.4.1742 Heinricher, 2001, Circuitry underlying anti-opioid actions of cholecystokinin within the rostral ventromedial medulla., J Neurophysiol, 85, 280, 10.1152/jn.2001.85.1.280 Hoffmann, 1994, The CCK-B receptor antagonist CI 988 reverses tolerance to morphine in rats., NeuroReport, 5, 2565, 10.1097/00001756-199412000-00040 Jacquet, 1976, The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections., Brain Res, 103, 501, 10.1016/0006-8993(76)90448-0 Kubota, 1983, The distribution of cholecystokinin octapetide-like structures in the lower brain stem of the rat: an immunohistochemical analysis., Neuroscience, 9, 587, 10.1016/0306-4522(83)90176-8 Li, 1989, Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat., Brain Res, 480, 105, 10.1016/0006-8993(89)91572-2 Liu, 1994, Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies., Brain Res, 642, 83, 10.1016/0006-8993(94)90908-3 Miller, 1997, Cholecystokinin increases GABA release by inhibiting a resting K conductance in hippocampal interneurons., J Neurosci, 17, 4994, 10.1523/JNEUROSCI.17-13-04994.1997 Moreau, 1986, -L.S, Fields HL. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission., Brain Res, 397, 37, 10.1016/0006-8993(86)91367-3 Siuciak, 1987, Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine., Brain Res, 424, 311, 10.1016/0006-8993(87)91476-4 Stanfa, 1993, Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation., Br J Pharmacol, 108, 967, 10.1111/j.1476-5381.1993.tb13493.x Tortorici, 2000, Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla., Pain, 89, 237, 10.1016/S0304-3959(00)00367-5 Tortorici, 1999, Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat., Behav Neurosci, 113, 833, 10.1037/0735-7044.113.4.833 Valverde, 1994, Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins., J Pharmacol Exp Ther, 270, 77 Vanegas, 1984, Tail-flick related activity in medullospinal neurons., Brain Res, 321, 135, 10.1016/0006-8993(84)90689-9 Vaughan, 1997, How opioids inhibit GABA-mediated neurotransmission., Nature (Lond), 390, 611, 10.1038/37610 Watkins, 1985, Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates., Brain Res, 327, 181, 10.1016/0006-8993(85)91512-4 Watkins, 1984, Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide., Science, 224, 395, 10.1126/science.6546809 Watkins, 1985, Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide., Brain Res, 327, 169, 10.1016/0006-8993(85)91511-2 Wiesenfeld-Hallin, 1999, Opioid sensitivity in antinociception: role of anti-opioid systems with emphasis on cholecystokinin and NMDA receptors., Prog Pain Res Manage, 14, 237 Xu, 1992, CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat., Br J Pharmacol, 105, 591, 10.1111/j.1476-5381.1992.tb09024.x Zhou, 1992, Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine., NeuroReport, 3, 1121, 10.1097/00001756-199212000-00022 Zhou, 1993, Increased release of immunoreactive cholecystokinin octapetide by morphine and potentiation of -opioid analgesia by CCKB receptor antagonist L-365, 260 in rat spinal cord., Eur J Pharmacol, 234, 147, 10.1016/0014-2999(93)90948-H